Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
HilleVax Closes $135 Million Crossover Financing to Advance Clinical Stage Norovirus Vaccine Candidate
Life Sciences Times
-
September 8, 2021
0
Venture Capital
Definitive Healthcare Announces Launch of Initial Public Offering
Life Sciences Times
-
September 7, 2021
0
Venture Capital
Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market
Life Sciences Times
-
September 7, 2021
0
Venture Capital
Enpro Continues Portfolio Reshaping; Divests Polymer Components Business
Life Sciences Times
-
September 3, 2021
0
Venture Capital
Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally
Life Sciences Times
-
September 2, 2021
0
Venture Capital
Saint-Gobain Life Sciences Acquires Equflow B.V.
Life Sciences Times
-
September 2, 2021
0
People on the Move
Thrive Global Appoints Veteran Product Leader Christopher O’Donnell Chief Product Officer On the Heels of $80 Million Series C Raise
Life Sciences Times
-
September 1, 2021
0
Venture Capital
Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster
Life Sciences Times
-
September 1, 2021
0
Venture Capital
GHO Capital invests in ClearView Healthcare Partners
Life Sciences Times
-
September 1, 2021
0
Venture Capital
Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections to Become Publicly Traded Through a Merger with Petra...
Life Sciences Times
-
August 31, 2021
0
Venture Capital
AgFunder Closes $21 Million Alternative Protein Fund Oversubscribed
Life Sciences Times
-
August 26, 2021
0
Venture Capital
Aditxt Announces Pricing of $11.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Life Sciences Times
-
August 26, 2021
0
1
...
100
101
102
...
115
Page 101 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026